Work

CD4+ T Cells Play Distinct Roles during the Priming versus Effector Phases of Immune Checkpoint Therapy–Dependent Tumor Elimination by CD8+ T Cells

Year: 2026

Type: article

Source: Cancer Immunology Research

DOI: 10.1158/2326-6066.cir-25-1652

Authors: Samuel Ameh, Derek J. Theisen, Mahima Thapa, Jackson S. Turner, Abhinav Rangarajan, Christopher A. Nelson, Aaron J. Schmitz, Yuang Song, Ruan F. Vieira Medrano, Cora D. Arthur, J. Michael White, Kathleen C.F. Sheehan, Daved H. Fremont, Ali H. Ellebedy, Hussein Sultan, Robert D. Schreiber

Institutions: Washington University in St. Louis, Parker Institute for Cancer Immunotherapy

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Research Foundation, Parker Institute for Cancer Immunotherapy, National Cancer Institute

Award: G6307724573

OpenAlex ID: W7169164256

FWCI:

Cites: 60

Cited by:

Related to: